Galien Golden Jubilee Forum USA 2021

PANEL 3
Oct. 28th, 2021
10:30AM – 11:30AM


In-person registrationLive broadcast registration

Co-Chairs:
Joel S. Marcus, Co-Founder, Alexandria Summit; Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
Lynne Zydowsky, President & Co-Founder, Alexandria Summit; Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Panelists:
Honorable Patrick Kennedy, Former U.S. Representative (D-RI); Founder, The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction and the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US
Richard Pops, Chairman & Chief Executive Officer, Alkermes
Marti Taylor, President & Chief Executive Officer, OneFifteen


PANEL INTROFULL PROGRAM

Co-Chairs
Joel S. Marcus
Co-Founder, Alexandria Summit;
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Joel Marcus is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. (NYSE:ARE), the urban office REIT that pioneered the life science real estate niche in 1994 and is longest-tenured owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, and Seattle.

Prior to serving as the company’s full-time Executive Chairman, Mr. Marcus served as CEO from March 1997 to April 2018 and also as Chairman from May 2007 to April 2018. Since co-founding Alexandria as a garage startup with $19 million in Series A capital, he has led its growth into an S&P 500 company with a total market cap of over $27 billion. In 1996, he founded Alexandria Venture Investments, the company’s venture capital arm, to strategically invest in promising life science, technology, and agtech companies that will positively impact people’s lives.

In 2011, Mr. Marcus co-founded the Alexandria Summit® as a highly collaborative, neutral platform that convenes its preeminent global life science and healthcare networks to address the most critical challenges facing human health. He serves on the boards of Applied Therapeutics (NASDAQ:APLT), Frequency Therapeutics (NASDAQ:FREQ), Intra-Cellular Therapies (NASDAQ:ITCI), MeiraGTx (NASDAQ:MGTX), the Emily Krzyzewski Center, FNIH, the National Medal of Honor Museum, the Navy SEAL Foundation, the Parker Institute for Cancer Immunotherapy, and Robin Hood. Additionally, he serves as a trustee of the 9/11 Memorial & Museum.


Co-Chairs
Lynne Zydowsky
President & Co-Founder, Alexandria Summit;
Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Lynne Zydowsky, PhD, President and Co-Founder of the Alexandria Summit and Chief Science Officer of Alexandria Real Estate Equities, Inc./Alexandria Venture Investments, and President of Zydowsky Consultants, is an experienced executive in the life science industry who has been involved in the launching and building of several successful companies. With over 20 years of experience, she has played key roles in corporate development, operations, and finance. She is a longstanding advocate for biomedical research and the advancement of global health.

In 2003, Dr. Zydowsky founded Zydowsky Consultants, a consulting practice offering services to life science companies. Prior to that, Dr. Zydowsky was Co-Founder and Chief Operating Officer of Renovis, Inc. (now Evotec) and served as Vice President of Pharmaceutical Business Development at Exelixis, Inc. As part of their executive management teams, she contributed to the growth and development of both companies, which led to their initial public offerings.

The Alexandria Summit, a neutral, interactive platform, co-founded in 2011 by Mr. Joel Marcus, Dr. Zydowsky, and Ms. Deeda Blair, convenes a diverse group of visionary stakeholders for transformative discussions and collaborations that help drive the discovery and development of novel, cost-effective therapies; shape policy to advance innovation that saves lives and cures disease; and inspires new ways of addressing the urgent need to transform our healthcare system.

Dr. Zydowsky currently serves on the Board of Directors for the Reagan-Udall Foundation for the FDA (since October 2018), Yumanity Therapeutics (since 2019), and Vindara, for which she is Board Chair (since 2019); the Board of Trustees for Butler University (since September 2016); and the Discovery Council for Harvard Medical School (since August 2018). She serves as a Board Observer for OneFifteen, a non-profit healthcare ecosystem dedicated to the full and sustained recovery of people living with opioid addiction, on behalf of Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. Dr. Zydowsky is also a key member of Alexandria’s COVID-19 Task Force.

Dr. Zydowsky is also personally engaged in critical philanthropic efforts as a member of the West Coast Board for the international non-profit buildOn, an organization focused on breaking the cycle of poverty, illiteracy, and low expectations through its after-school programs for urban teens based on changing lives and communities through service locally and globally.

Dr. Zydowsky earned her PhD in Chemistry from The Ohio State University and was a National Institutes of Health postdoctoral fellow in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. She has a Bachelor of Science degree in Pharmacy from Butler University.


Honorable Patrick Kennedy
Former U.S. Representative (D-RI);
Founder, The Kennedy Forum;
Former Member, President’s Commission on Combating Drug Addiction and the Opioid Crisis;
Co-Founder, One Mind;
Co-Chair, Mental Health for US

During his time in Congress, Patrick J. Kennedy was the lead author of the landmark Mental Health Parity and Addiction Equity Act (Federal Parity Law), which requires insurers to cover treatment for mental health and substance use disorders no more restrictively than treatment for illnesses of the body, such as diabetes and cancer. In 2013, he founded The Kennedy Forum, a nonprofit that unites advocates, business leaders, and government agencies to advance evidence-based practices, policies, and programming in mental health and addiction. In 2015, Mr. Kennedy co-authored the New York Times bestseller, A Common Struggle: A Personal Journey Through the Past and Future of Mental Illness and Addiction, which details a bold plan for the future of mental health care in America. In 2017, he was appointed to the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

Mr. Kennedy is also the founder of DontDenyMe.org, an educational campaign that empowers consumers and providers to understand parity rights and connects them to essential appeals guidance and resources; co-founder of One Mind, an organization that pushes for greater global investment in brain research; co-chair of the National Action Alliance for Suicide Prevention’s Mental Health & Suicide Prevention National Response to COVID-19 (National Response); and co-chair of the Bipartisan Policy Center’s Behavioral Health Integration Task Force.


Richard Pops
Chairman & Chief Executive Officer
Alkermes

Richard Pops serves as Alkermes’ Chairman and Chief Executive Officer. He joined Alkermes as CEO in 1991, and under his leadership, the organization has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 2,000 employees.

Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, the Biotechnology Industry Organization (BIO), and the Pharmaceutical Research and Manufacturers of America (PhRMA).


Marti Taylor
President & Chief Executive Officer
OneFifteen

Ms. Taylor started her career in 1986 after graduating from Capital University in Columbus, Ohio with a Bachelor of Science in Nursing. She began as a staff nurse in the Cardiac Intensive Care Unit at Duke University Hospital and during that time went on to graduate from Duke University with a Master of Science in Nursing in 1993. It was during her 25-plus years at Duke that she fell in love with academics, research, teaching, clinical care, and mentorship to others.

While at Duke, Ms. Taylor supervised all aspects of the Health Systems Heart Center at three hospitals and multiple affiliate hospitals. From 2003 to 2007, she served as President of the Saint Joseph’s Cardiovascular Program and Research Institute in Atlanta. Most recently, she served as Chief Executive Officer of University Hospital and the Ross Heart Hospital at The Ohio State University Wexner Medical Center. In that role, she was responsible for leading more than 5,000 employees and a budget totaling more than $1.8 billion. Ms. Taylor has served on a number of boards during her time in North Carolina, Georgia, and Ohio. Today, she serves as Executive Director of Behavioral Health at Verily and the President and CEO of OneFifteen, an addiction treatment program offering services in Dayton, Ohio. She currently serves on the Board of Trustees for Capital University and the Dayton Development Coalition Board. Ms. Taylor and her husband, Rodney, have two teenage boys, Zachary and Andrew.